These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25423566)

  • 21. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-744-5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells.
    Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zheng J; Lu X
    Exp Cell Res; 2020 Jul; 392(1):112024. PubMed ID: 32335029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1.
    Tan J; Li C; Ren L; Zhu X; Hua F; Fu Y
    Mol Cell Probes; 2022 Dec; 66():101863. PubMed ID: 36252912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
    Wang XZ; Hang YK; Liu JB; Hou YQ; Wang N; Wang MJ
    J Pharmacol Sci; 2016 Feb; 130(2):78-84. PubMed ID: 26806295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma.
    Zang CS; Huang HT; Qiu J; Sun J; Ge RF; Jiang LW
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4890-4900. PubMed ID: 32432752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
    Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
    J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14.
    Wang WJ; Yuan Y; Zhang D; Liu P; Liu F
    Kaohsiung J Med Sci; 2021 Nov; 37(11):983-990. PubMed ID: 34292652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
    Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
    Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
    Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q
    Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
    Jia M; Shi Y; Li Z; Lu X; Wang J
    Cancer Lett; 2019 Feb; 443():145-156. PubMed ID: 30503553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
    Wei H; Pan L; Tao D; Li R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):56-61. PubMed ID: 29842886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
    Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
    J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
    Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y
    Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
    Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
    J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.